Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs

Bibliographic Details
Main Authors:	Elizabeth Docteur, Ruth Lopert
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2015-12-01
Series:	Journal of Pharmaceutical Policy and Practice
Subjects:	OECD Country Alternative Policy Reimbursement Decision Total Spending Policy Expert
Online Access:	https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-O2

Similar Items

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
by: Elizabeth Docteur, et al.
Published: (2015-12-01)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
by: Andrew L Gray
Published: (2015-12-01)

The Impact of Healthcare Spending on Health Outcomes: New Evidence from OECD Countries
by: Sevilay Karaman, et al.
Published: (2020-04-01)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017-01-01)

The impact of Ghana’s National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
by: Dumebi O Mordi, et al.
Published: (2015-12-01)

Public spending on Energy innovations and CO2 impacts: Evidence from selected OECD countries
by: Sayyed Mahdi Ziaei
Published: (2025-01-01)

Drug pricing and reimbursement decision making systems in Mongolia
by: Gereltuya Dorj, et al.
Published: (2017-12-01)

Reimbursement measures in European countries – findings of a bibliometric literature review
by: Sabine Vogler, et al.
Published: (2015-12-01)

Food insecurity indicators of 14 OECD countries in a health economics aspect: A comparative analysis
by: Salim Yılmaz, et al.
Published: (2023-04-01)

Does military spending stifle economic growth? The empirical evidence from non-OECD countries
by: Muhammad Azam
Published: (2020-12-01)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
by: Hajer Dahmani, et al.
Published: (2023-12-01)

Managing mental health: why we need to redress the balance between healthcare spending and social spending
by: Daniel S. Park, et al.
Published: (2020-03-01)

Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal
by: Vidhi Thakkar, et al.
Published: (2017-11-01)

The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer
by: Sarah Sharman Moser, et al.
Published: (2023-02-01)

The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
by: Féline E. V. Scheijmans, et al.
Published: (2022-11-01)

A Comparison of the Macroeconomic Effects of Increased Defence Spending in Poland and Germany
by: Piotr Krajewski, et al.
Published: (2023-12-01)

Pharmaceutical pricing policy in Greece: towards a different path.
by: Kyriakos Souliotis, et al.
Published: (2016-08-01)

ABOUT THE ROLE OF GOVERNMENT SPENDING IN THE PROCESSES OF FINANCIAL POLICY
by: V. Ye. Vlasiuk
Published: (2008-08-01)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
by: Szczepan Jakubowski, et al.
Published: (2024-03-01)

Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries
by: Szczepan Jakubowski, et al.
Published: (2024-11-01)

Trade openness, growth, income inequality and environment in developing and OECD countries
by: Idris, Jamilah
Published: (2015)

Review of Publicly Available State Reimbursement Policies for Removal and Reinsertion of Long-Acting Reversible Contraception
by: Okoroh EM, et al.
Published: (2024-11-01)

Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey's Health Care System?
by: Guvenc Kockaya, et al.
Published: (2010-01-01)

The timelines for the price and reimbursement authorization in Italy 2018–2020
by: Valentina Gallo, et al.
Published: (2022-12-01)

The effect of fiscal policy in terms of government spending on private consumption in recessions and booms in Iran
by: Neda Kassaipour, et al.
Published: (2012-10-01)

Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU
by: SungKyung Lee, et al.
Published: (2023-02-01)

Impact of an expanded reimbursement policy on utilization of implantable loop recorders in patients with cryptogenic stroke in Korea
by: Hye Bin Gwag, et al.
Published: (2024-05-01)

Migration Policy in the Area of Border Control and Migration of the Population in OECD Countries –Theoretical and Practical Aspects
by: Katarzyna Woźniak
Published: (2020-12-01)

Sexism and Attitudes Toward Policy Spending in Australia and the United States
by: Katrine Beauregard, et al.
Published: (2022-05-01)

Reimbursement process of medicinal products in Poland and in the world
by: Aneta Katarzyna Mela
Published: (2020-09-01)

Evolving teledermatology policy and reimbursement landscape in the United StatesCapsule Summary
by: Stephanie K. Lin, BA, et al.
Published: (2023-06-01)

Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria
by: Georgi Iskrov, et al.
Published: (2016-02-01)

Effects of government spending on economic growth, poverty and institutional quality in Asian countries
by: Liew, Chung Yee
Published: (2017)

A scoping review of the payment mechanisms in childbirth of country members and non-members of the Organisation for Economic Co-operation and Development
by: Karla Hernández-Sánchez, et al.
Published: (2020-05-01)

A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries
by: Marcin Czech, et al.
Published: (2020-01-01)

Understanding the relationships between health spending, treatable mortality and economic productivity in OECD countries
by: Viera Ivankova, et al.
Published: (2022-12-01)

Savunma Harcamaları ve Ekonomik Büyüme İlişkisi: OECD Ülkeleri İçin Panel Eşik Değer Analizi(Defense Expenditures and Economic Growth Relationship: Panel Threshold Analysis for OECD Countries)
by: Özgür KOÇBULUT, et al.
Published: (2021-09-01)

Government spending and land values : public money and private gain/
by: Harriss, C. Lowell
Published: (1973)

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
by: Ewa Stawowczyk, et al.
Published: (2019-11-01)